Project Description M/s STELIS Biopharma Pvt. Ltd., is a new biopharmaceutical facility to manufacture Monoclonal Antibodies and Therapeutic Proteins. The plant is proposed to be constructed on about 10 acres of land. Products to be manufactured are Products to be manufactured are: Monoclonal Antibodies Therapeutic Proteins. The plant’s locational advantages regarding the infrastructural facilities like power, water, and roads are fully developed and connected to National Highways. This is well